Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET) Invested Capital (2016 - 2026)

Metlife's Invested Capital history spans 18 years, with the latest figure at $42.0 billion for Q1 2026.

  • Quarterly Invested Capital fell 0.97% to $42.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.0 billion through Mar 2026, down 0.97% year-over-year, with the annual reading at $43.1 billion for FY2025, 0.25% changed from the prior year.
  • Invested Capital came in at $42.0 billion for Q1 2026, down from $43.1 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $56.6 billion in Q1 2022 to a low of $41.4 billion in Q3 2023.
  • The 5-year median for Invested Capital is $44.2 billion (2025), against an average of $45.0 billion.
  • Year-over-year, Invested Capital crashed 47.01% in 2022 and then grew 12.26% in 2024.
  • Metlife's Invested Capital stood at $44.8 billion in 2022, then rose by 2.56% to $45.9 billion in 2023, then decreased by 5.81% to $43.3 billion in 2024, then dropped by 0.25% to $43.1 billion in 2025, then dropped by 2.57% to $42.0 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Invested Capital are $42.0 billion (Q1 2026), $43.1 billion (Q4 2025), and $44.2 billion (Q3 2025).